VU

Valence8 US Portfolio holdings

AUM $238M
This Quarter Return
-2.5%
1 Year Return
+14.65%
3 Year Return
5 Year Return
10 Year Return
AUM
$208M
AUM Growth
+$208M
Cap. Flow
-$13.6M
Cap. Flow %
-6.54%
Top 10 Hldgs %
100%
Holding
57
New
1
Increased
4
Reduced
5
Closed
31
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
CRNX icon
26
Crinetics Pharmaceuticals
CRNX
$2.92B
-6,684
Closed -$342K
CRSP icon
27
CRISPR Therapeutics
CRSP
$4.71B
0
ENTA icon
28
Enanta Pharmaceuticals
ENTA
$180M
-19,939
Closed -$207K
ERAS icon
29
Erasca
ERAS
$445M
-46,923
Closed -$128K
GOSS icon
30
Gossamer Bio
GOSS
$562M
0
INDV icon
31
Indivior
INDV
$3.03B
-57,293
Closed -$564K
INSM icon
32
Insmed
INSM
$28.8B
-7,865
Closed -$574K
IOVA icon
33
Iovance Biotherapeutics
IOVA
$807M
0
JANX icon
34
Janux Therapeutics
JANX
$1.37B
-7,857
Closed -$357K
JAZZ icon
35
Jazz Pharmaceuticals
JAZZ
$7.75B
-8,969
Closed -$999K
KROS icon
36
Keros Therapeutics
KROS
$618M
-8,025
Closed -$466K
KZR icon
37
Kezar Life Sciences
KZR
$28.9M
-21,136
Closed -$16.3K
LLY icon
38
Eli Lilly
LLY
$657B
-633
Closed -$561K
LPTX icon
39
Leap Therapeutics
LPTX
$12M
-18,511
Closed -$47.6K
MRNA icon
40
Moderna
MRNA
$9.37B
0
NKTR icon
41
Nektar Therapeutics
NKTR
$568M
-26,107
Closed -$33.9K
NTLA icon
42
Intellia Therapeutics
NTLA
$1.22B
-13,020
Closed -$268K
NUVL icon
43
Nuvalent
NUVL
$5.52B
-4,115
Closed -$421K
NVO icon
44
Novo Nordisk
NVO
$251B
0
PCVX icon
45
Vaxcyte
PCVX
$4B
-2,468
Closed -$282K
RARE icon
46
Ultragenyx Pharmaceutical
RARE
$2.89B
-4,241
Closed -$236K
RLAY icon
47
Relay Therapeutics
RLAY
$619M
-26,200
Closed -$185K
SAVA icon
48
Cassava Sciences
SAVA
$110M
0
SLDB icon
49
Solid Biosciences
SLDB
$427M
-15,728
Closed -$110K
SLNO icon
50
Soleno Therapeutics
SLNO
$3.6B
-9,706
Closed -$490K